Feb 11, 2020 / 03:15PM GMT
Unidentified Participant
There is a company presentation breakout room in the O'Neal Room. Please feel free to continue the conversation with the presenter there immediately following this presentation. Our next presenting company will be Outlook Therapeutics and presenting will be Larry Kenyon, President and CEO.
Larry Kenyon - Outlook Therapeutics, Inc. - President, CEO & CFO
Thank you very much and thank you for taking the time for today's presentation from Outlook Therapeutics. As you just learned, my name is Larry Kenyon; I am President, CEO and CFO at Outlook.
A quick moment here to run through our disclaimer. There will be forward-looking statements in today's presentation. To stay up-to-date on those forward-looking statements, please go to our Company website on the Investor Relations page.
Outlook Therapeutics is a Phase 3 clinical stage biopharma company uniquely positioned to excel in the large and growing ophthalmics market. Our lead candidate is ONS-5010, an ophthalmic formulation of bevacizumab with a well-defined regulatory pathway.
Outlook Therapeutics Inc at Biotechnology Industry Organization (BIO) CEO & Investor Conference Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers